These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23184046)

  • 1. Androgen receptor GGC polymorphism and testosterone levels associated with high risk of prostate cancer and benign prostatic hyperplasia.
    Biolchi V; Silva Neto B; Pianta DB; Koff WJ; Berger M; Brum IS
    Mol Biol Rep; 2013 Mar; 40(3):2749-56. PubMed ID: 23184046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk.
    Salinas CA; Austin MA; Ostrander EO; Stanford JL
    Prostate; 2005 Sep; 65(1):58-65. PubMed ID: 15810021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
    Zambra FM; Biolchi V; Brum IS; Chies JA
    Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
    Binnie MC; Alexander FE; Heald C; Habib FK
    Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor polymorphisms and the incidence of prostate cancer.
    Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors.
    Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N
    Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
    Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
    Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive association of the androgen receptor CAG repeat length polymorphism with the risk of prostate cancer.
    Paz-Y-Miño C; Robles P; Salazar C; Leone PE; García-Cárdenas JM; Naranjo M; López-Cortés A
    Mol Med Rep; 2016 Aug; 14(2):1791-8. PubMed ID: 27357524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.
    Alptekin D; Izmirli M; Bayazit Y; Luleyap HU; Yilmaz MB; Soyupak B; Erkoc MA; Tansug Z
    Genet Mol Res; 2012 May; 11(2):1424-32. PubMed ID: 22653589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
    Das K; Cheah PY; Lim PL; Zain YB; Stephanie FC; Zhao Y; Cheng C; Lau W
    Cancer Lett; 2008 Sep; 268(2):340-7. PubMed ID: 18495332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor gene GGN microsatellite and prostate cancer risk.
    Platz EA; Giovannucci E; Dahl DM; Krithivas K; Hennekens CH; Brown M; Stampfer MJ; Kantoff PW
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):379-84. PubMed ID: 9610786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer.
    Kucerova R; Bienova M; Kral M; Bouchal J; Trtkova KS; Burdova A; Student V; Kolar Z
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):91-6. PubMed ID: 24665929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
    Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer.
    Schatzl G; Madersbacher S; Haitel A; Gsur A; Preyer M; Haidinger G; Gassner C; Ochsner M; Marberger M
    J Urol; 2003 Apr; 169(4):1312-5. PubMed ID: 12629350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
    Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
    Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.